Yahoo
Shenzhen - Delayed Quote CNY

Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ)

12.05 +0.08 (+0.67%)
At close: October 30 at 3:04:25 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
6,170,748.38
6,482,731.70
6,103,269.11
7,979,899.32
10,609,442.08
Cost of Revenue
2,417,769.52
2,333,260.82
2,387,647.10
2,853,285.89
3,983,285.82
Gross Profit
3,752,978.86
4,149,470.88
3,715,622
5,126,613.43
6,626,156.26
Operating Expense
2,658,672.84
2,610,869.15
2,998,666.06
3,281,992.48
3,767,316.65
Operating Income
1,094,306.02
1,538,601.73
716,955.95
1,844,620.95
2,858,839.61
Net Non Operating Interest Income Expense
-219,494.92
-111,238.70
-69,158.63
-59,550.89
-108,715.57
Pretax Income
697,132.25
1,216,078.13
225,760.65
1,554,497.96
2,611,781.61
Tax Provision
72,491.24
197,074.52
28,466.78
262,147.01
365,726.11
Net Income Common Stockholders
658,241.90
962,006.33
246,937.72
1,258,200.34
2,203,779.37
Basic EPS
0.36
0.52
0.13
0.68
1.22
Diluted EPS
0.36
0.52
0.13
0.68
1.21
Basic Average Shares
1,843,004.81
1,843,277.13
1,848,336.19
1,862,069.47
1,802,240.25
Diluted Average Shares
1,843,004.81
1,843,277.13
1,848,336.19
1,862,069.47
1,816,950.59
Total Operating Income as Reported
697,605.79
1,220,070.43
253,139.31
1,547,215.14
2,623,138.70
Rent Expense Supplemental
42,786.83
32,024.37
45,588.16
40,293.16
26,342.87
Total Expenses
5,076,442.37
4,944,129.97
5,386,313.16
6,135,278.37
7,750,602.47
Net Income from Continuing & Discontinued Operation
658,241.90
962,006.33
246,937.72
1,258,200.34
2,203,779.37
Normalized Income
844,477.01
1,135,485.75
536,952.29
1,421,100.52
2,262,075.39
Interest Income
57,159.30
71,511.76
115,513.07
115,343.17
87,989.30
Interest Expense
264,434
176,640.43
181,000
170,645.10
188,775.14
Net Interest Income
-219,494.92
-111,238.70
-69,158.63
-59,550.89
-108,715.57
EBIT
961,566.25
1,392,718.56
406,760.65
1,725,143.05
2,800,556.75
EBITDA
961,566.25
2,031,521.95
966,799.28
2,238,702.63
3,289,029.24
Reconciled Cost of Revenue
2,417,769.52
2,333,260.82
2,387,647.10
2,853,285.89
3,983,285.82
Reconciled Depreciation
598,013.16
638,803.39
560,038.63
513,559.58
488,472.49
Net Income from Continuing Operation Net Minority Interest
658,241.90
962,006.33
246,937.72
1,258,200.34
2,203,779.37
Total Unusual Items Excluding Goodwill
-207,848.19
-207,030.20
-331,859.68
-195,943.68
-67,788.38
Total Unusual Items
-207,848.19
-207,030.20
-331,859.68
-195,943.68
-67,788.38
Normalized EBITDA
1,169,414.43
2,238,552.15
1,298,658.96
2,434,646.32
3,356,817.62
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-21,613.08
-33,550.79
-41,845.10
-33,043.50
-9,492.36
12/31/2022 - 10/30/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: